UFC flyweight Sarah Frota will have to sit for the next two years following a positive drug test for steroids.
USADA (United States Anti-Doping Agency), who oversee the UFC’s anti-doping program, announced the suspension Tuesday.
“Frota Lima, 32, tested positive for multiple stanozolol metabolites, including 16α-hydroxystanozolol, 3’,16-dihydroxystanozolol, and 4β,16-dihydroxystanozolol, as the result of an in-competition urine sample she provided on July 27, 2019 at UFC 240 Edmonton, where she lost by technical knockout,” USADA officials wrote in the statement.
Stanozolol is a synthetic anabolic steroid that came to prominence in the 1980s when Olympic runner Ben Johnson tested positive for the drug and was later stripped of his gold medal. Several UFC fighters have tested positive for stanozolol in the past including Ruslan Magomedov, who received a lifetime ban from the USADA following multiple infractions of the UFC’s anti-doping policy.
Frota’s suspension was made retroactive to the date of her test on July 27, which was the night she suffered a second-round TKO loss to Gillian Robertson at UFC 240 in Edmonton.
The positive drug test also falls under the jurisdiction of the Edmonton Combative Sports Commission, who accepted the two-year suspension handed down by USADA.
After going 0-2 in her brief stint with the promotion, sources confirmed to MMA Fighting’s Guilherme Cruz that Frota was released from the UFC. She won’t be eligible to compete again until after July 27, 2021.